Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : 2019 Biotech Charity Contest -- Ignore unavailable to you. Want to Upgrade?

To: BulbaMan who wrote (108)	2/1/2019 7:30:37 PM
From: BulbaMan	Read Replies (1) \| Respond to of 280

2/1/2019 Contest update The U.S., this afternoon, officially suspended its nuclear arms control treaty with Russia. But experts say the treaty suspension has less to do with Russia than with China, in that the treaty has constrained the U.S. from building more nuclear weapons to counter China’s growing arsenal. As noted by the Union of Concerned Scientists, our stable genius POTUS once “wondered aloud why we have nuclear weapons if we wouldn’t use them.” Is it really... I guess I’m OT. Along with the broader market, biotechs had a decent week and began 2019's second month with a happy face. At Friday’s close, the Contest median was up 13.33% YTD (vs. 11.71% YTD a week ago), the Nasdaq Biotech Index (NBI) was up 13.99% YTD (vs. 13.05% YTD a week ago), the smaller-cap S&P Biotechnology Select Industry Index (SPSIBI) was up 16.64% YTD (vs. 14.46% YTD a week ago) and the Nasdaq Composite Index (NCI) was up 9.47% YTD (vs. up 7.98% YTD a week ago). HOOD’s portfolio, up 32.21% YTD, had a superb week and remained in the Contest lead. SANCTU’s portfolio, up 27.49% YTD, held on to second place, while RKRW’s portfolio, up 25.82% YTD, jumped into third place. At Friday's close, 38 of the 39 Contest portfolios were in the green, with 18 beating the NBI and 12 still beating the pumped SPSIBI. The 167 Contest stock picks have an average YTD gain of 16.01% and a median YTD gain of 12.29%. Below is the Top Ten list. Also below are the Top 5 & Bottom 5 Stocks for the week ranked by % Gained and % Lost YTD. (Prices not converted to US$ in these Tables.) Portfolio adjustments: None. (All corrections, especially adjustments for splits & mergers, greatly appreciated.) Have a safe and relaxing Super Bowl LIII weekend biotechies! Peace & good health, Bulba 2/1/19 Rank Name Profit/Loss 1 HOOD 32,212 2 SANCTU 27,488 3 RKRW 25,819 4 DEWDIL 24,584 5 JACKH 24,433 6 BIOADD 20,314 7 FILO 19,587 8 BIOMAV 18,604 9 GENE 18,389 10 ANDRE 18,194 Week's Top 5 Gainers Symbol YE2018 2/1/19 Wk.%chg. CLDX 0.347 0.579 66.82% PLX 0.434 0.550 26.69% VYGR 8.450 10.550 24.85% APVO 1.380 1.710 23.91% MGTX 10.020 12.270 22.46% Week's Worst 5 Losers Symbol YE2018 2/1/19 Wk.%chg. LPTX 3.000 1.500 -50.00% MRKR 5.980 5.240 -12.37% SENS 2.700 2.410 -10.74% AGN 160.660 144.070 -10.33% ALNA 8.020 7.220 -9.98%